Legal Representation
Attorney
Kaushal R. Odedra
USPTO Deadlines
Next Deadline
1341 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-07-14)
Due Date
July 14, 2029
Grace Period Ends
January 14, 2030
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 4, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 10, 2019 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Apr 10, 2019 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Apr 10, 2019 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Apr 8, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Jul 14, 2018 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Aug 5, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Aug 5, 2015 | 8.PR | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | Loading... |
| Aug 5, 2015 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Jul 1, 2015 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Jul 14, 2009 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 28, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 8, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 23, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 23, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 24, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 24, 2009 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 23, 2009 | I | PAPER RECEIVED | Loading... | |
| Feb 10, 2009 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Feb 9, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2009 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 9, 2009 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Feb 6, 2009 | I | PAPER RECEIVED | Loading... | |
| Jan 12, 2009 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Jan 11, 2009 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Dec 11, 2008 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Nov 19, 2008 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jun 11, 2008 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 11, 2008 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Jun 10, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 10, 2008 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jun 9, 2008 | I | PAPER RECEIVED | Loading... | |
| Mar 26, 2008 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Mar 25, 2008 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Feb 24, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 24, 2008 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Aug 24, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 24, 2007 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Aug 24, 2007 | CNSL | F | LETTER OF SUSPENSION MAILED | Loading... |
| May 16, 2007 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
[Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases]
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
040
042